Deuterated rapaymcin can be controllably introduced target locations within the patient's body by using an implantable medical device having a structure incorporated with a therapeutic agent comprising a deuterated rapamycin. Representative deuterated rapamycins include epi-7-deuteromthyl rapamycin,...http://www.google.es/patents/US20030130206?utm_source=gb-gplus-sharePatente US20030130206 - Medical devices incorporating deuterated rapamycin for controlled delivery thereof
Medical devices incorporating deuterated rapamycin for controlled delivery ...
Número de solicitud: 10/301,504 Número de publicación: US 2003/0130206 A1 Fecha de presentación: 20 Nov 2002 Patente emitida: US6884429 ( Fecha de emisión 26 Abr 2005)
